CATHY BOWLIN: Open Payments
NPI 1316068414 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 18 payments from 8 companies in 2025. Trend: 2023 $604 · 2024 $479 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $219 |
| Novo Nordisk Inc | 4 | $82 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| ABBVIE INC. | 1 | $19 |
| Amgen Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| SHIELD THERAPEUTICS INC | 1 | $15 |
Products named: Kerendia, Ozempic, BREZTRI, UBRELVY, Rybelsus, REPATHA, Veozah, XIFAXAN.
Industry payments across TX — which companies pay providers there.
